Moving young people with rheumatic diseases from paediatric to adult care

Introduction Recommendations give advice to doctors, other health professionals, patients and their families about the best way to treat and manage diseases. EULAR has written recommendations in partnership with Pediatric Rheumatology European Society (PReS) on the transitional care of young people with rheumatic diseases. Transitional care means moving young people from their childhood paediatric healthcare […]

Read More…

The management of lupus

Introduction Recommendations give advice to doctors and patients about the best way to treat and manage diseases. EULAR has written recommendations on the management of people with systemic lupus erythematosus (also called SLE or Lupus for short). Lupus is an autoimmune disease where the immune system attacks the body’s own tissues and causes inflammation. Lupus […]

Read More…

Vaccination for people with autoimmune inflammatory rheumatic diseases

Introduction Vaccinations are a way of preventing infections before they happen. Vaccines help the immune system to recognise viruses and bacteria that cause disease. Recommendations give advice to doctors and patients about the best way to treat and manage diseases. EULAR published in 2011 the current recommendations on vaccination for people with autoimmune inflammatory rheumatic […]

Read More…

Education for people with inflammatory arthritis

INTRODUCTION Patient education is a planned interactive learning process designed to support and enable people with inflammatory arthritis to manage their life and optimise their health. Patient education activities include giving help and advice on healthy living and how to stay well. Receiving patient education helps people to manage their own illness and to have […]

Read More…

Managing the use of glucocorticoid therapy in rheumatic disease

This is the patient version of the EULAR recommendations for the management of glucocorticoid medicines in people with rheumatic diseases. The original publication can be downloaded from the EULAR website: www.eular.org. INTRODUCTION Glucocorticoids (prednisone or prednisolone) are medicines to reduce inflammation. They are used in rheumatic diseases such as rheumatoid arthritis, polymyalgia, lupus and vasculitis […]

Read More…

Newly updated advice on the treatment of patients with AAV

INTRODUCTION A central focus of newly updated recommendations on treating ANCA-associated vasculitis (AAV) is shared decision-making between patients and doctors. The updated recommendations, produced by a collaboration between the European League Against Rheumatism (EULAR) and European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), taking account of recent research on the benefits and safety […]

Read More…

Joint EULAR and ACR recommendations for best practice in polymyalgia rheumatica

Steroids are the best option for patients with polymyalgia rheumatica. INTRODUCTION Polymyalgia rheumatica is an inflammatory condition that causes pain and stiffness in the muscles, usually around the upper arms, shoulders, neck and hips or thighs. The stiffness is worse in the mornings and can severely limit movement and activities. The cause of polymyalgia rheumatic […]

Read More…

EULAR recommendations for the use of imaging in spondyloarthritis

Imaging techniques are a key component of the classification of spondyloarthritis, allowing patients to be classi- fied into distinct groups and to receive the appropriate treatment. INTRODUCTION Spondyloarthritis is an umbrella term for several conditions that share many of the same features and symptoms, including ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Patients can also […]

Read More…